Recurrent SMARCB1 Mutations Reveal a Nucleosome Acidic Patch Interaction Site That Potentiates mSWI/SNF Complex Chromatin Remodeling.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
27 11 2019
Historique:
received: 17 05 2019
revised: 02 09 2019
accepted: 30 10 2019
pubmed: 25 11 2019
medline: 28 5 2020
entrez: 25 11 2019
Statut: ppublish

Résumé

Mammalian switch/sucrose non-fermentable (mSWI/SNF) complexes are multi-component machines that remodel chromatin architecture. Dissection of the subunit- and domain-specific contributions to complex activities is needed to advance mechanistic understanding. Here, we examine the molecular, structural, and genome-wide regulatory consequences of recurrent, single-residue mutations in the putative coiled-coil C-terminal domain (CTD) of the SMARCB1 (BAF47) subunit, which cause the intellectual disability disorder Coffin-Siris syndrome (CSS), and are recurrently found in cancers. We find that the SMARCB1 CTD contains a basic α helix that binds directly to the nucleosome acidic patch and that all CSS-associated mutations disrupt this binding. Furthermore, these mutations abrogate mSWI/SNF-mediated nucleosome remodeling activity and enhancer DNA accessibility without changes in genome-wide complex localization. Finally, heterozygous CSS-associated SMARCB1 mutations result in dominant gene regulatory and morphologic changes during iPSC-neuronal differentiation. These studies unmask an evolutionarily conserved structural role for the SMARCB1 CTD that is perturbed in human disease.

Identifiants

pubmed: 31759698
pii: S0092-8674(19)31221-8
doi: 10.1016/j.cell.2019.10.044
pmc: PMC7175411
mid: NIHMS1545307
pii:
doi:

Substances chimiques

Chromosomal Proteins, Non-Histone 0
Mutant Proteins 0
Nucleosomes 0
SMARCB1 Protein 0
SMARCB1 protein, human 0
SWI-SNF-B chromatin-remodeling complex 0
Transcription Factors 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1342-1356.e23

Subventions

Organisme : NINDS NIH HHS
ID : R35 NS105076
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA196539
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM095450
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD090255
Pays : United States
Organisme : NCI NIH HHS
ID : DP2 CA195762
Pays : United States
Organisme : NIGMS NIH HHS
ID : R37 GM086868
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
Nature. 1998 Jul 9;394(6689):203-6
pubmed: 9671307
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Hum Mol Genet. 2013 Dec 20;22(25):5121-35
pubmed: 23906836
Stat Appl Genet Mol Biol. 2007;6:Article9
pubmed: 17402924
Cell Host Microbe. 2015 Dec 9;18(6):723-35
pubmed: 26651948
Genes Dev. 1996 Sep 1;10(17):2117-30
pubmed: 8804307
Clin Genet. 2014 Jun;85(6):548-54
pubmed: 23815551
Cell Rep. 2016 Oct 18;17(4):1053-1070
pubmed: 27760312
Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50
pubmed: 27166375
Mol Cell. 2019 Sep 5;75(5):891-904.e7
pubmed: 31375262
Science. 1991 May 24;252(5009):1162-4
pubmed: 2031185
Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):241-51
pubmed: 25169878
Br J Cancer. 2001 Jan;84(2):199-201
pubmed: 11161377
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Mol Cell. 2014 May 8;54(3):392-406
pubmed: 24703950
Cell. 2018 Nov 15;175(5):1272-1288.e20
pubmed: 30343899
Front Mol Neurosci. 2018 Aug 03;11:252
pubmed: 30123105
Nat Cell Biol. 2018 Dec;20(12):1410-1420
pubmed: 30397315
Epigenetics. 2012 Nov;7(11):1219-24
pubmed: 23010866
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Eur Biophys J. 2009 Feb;38(2):129-43
pubmed: 18807026
Cell. 2010 Jun 11;141(6):943-55
pubmed: 20550931
J Biomol NMR. 2012 Apr;52(4):315-27
pubmed: 22331404
Brief Bioinform. 2013 Mar;14(2):144-61
pubmed: 22908213
J Biomol NMR. 2009 Aug;44(4):213-23
pubmed: 19548092
Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):262-75
pubmed: 25168959
Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):257-61
pubmed: 25081545
Nature. 2019 May;569(7754):136-140
pubmed: 30996347
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Nature. 2017 Aug 31;548(7669):607-611
pubmed: 28767641
Nat Protoc. 2006;1(1):241-5
pubmed: 17406239
Nat Genet. 2017 Nov;49(11):1613-1623
pubmed: 28945250
Neuron. 2013 Jun 5;78(5):785-98
pubmed: 23764284
Am J Hum Genet. 2012 Jul 13;91(1):73-82
pubmed: 22726846
Nat Rev Genet. 2013 May;14(5):347-59
pubmed: 23568486
Bioinformatics. 2016 Feb 15;32(4):587-9
pubmed: 26508757
Cell Syst. 2018 May 23;6(5):555-568.e7
pubmed: 29778836
BMC Genomics. 2014 Apr 15;15:284
pubmed: 24735413
Front Mol Neurosci. 2017 Aug 03;10:243
pubmed: 28824374
PLoS One. 2011;6(10):e26203
pubmed: 22022567
Science. 1994 Dec 23;266(5193):2002-6
pubmed: 7801128
Annu Rev Biochem. 1998;67:545-79
pubmed: 9759497
Annu Rev Biochem. 2009;78:273-304
pubmed: 19355820
Nat Genet. 2012 Mar 18;44(4):376-8
pubmed: 22426308
Cold Spring Harb Mol Case Stud. 2019 Jun 3;5(3):
pubmed: 31160358
Sci Adv. 2015 Jun 12;1(5):e1500447
pubmed: 26601204
Nature. 2017 Apr 27;544(7651):440-445
pubmed: 28424519
Nat Rev Genet. 2016 Jan;17(1):9-18
pubmed: 26503795
Mol Cell. 1999 Feb;3(2):247-53
pubmed: 10078207
Curr Protoc Mol Biol. 2015 Jan 05;109:21.29.1-21.29.9
pubmed: 25559105
Nucleic Acids Res. 2011 Jan;39(Database issue):D945-50
pubmed: 20952405
Genet Med. 2019 Mar;21(3):572-579
pubmed: 29907796
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Nat Genet. 2019 Apr;51(4):618-626
pubmed: 30858614
Hum Mutat. 2013 Nov;34(11):1519-28
pubmed: 23929686
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nature. 2015 Feb 19;518(7539):344-9
pubmed: 25693565
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Trends Genet. 2007 Aug;23(8):403-12
pubmed: 17566593
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Cell Rep. 2017 Feb 28;18(9):2124-2134
pubmed: 28249159
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
pubmed: 27899578
Nat Genet. 2012 Mar 18;44(4):379-80
pubmed: 22426309
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Am J Med Genet A. 2018 Nov;176(11):2250-2258
pubmed: 30276971
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
Cell Rep. 2017 Feb 28;18(9):2135-2147
pubmed: 28249160
J Mol Biol. 1997 Sep 26;272(3):301-11
pubmed: 9325091
Stat Appl Genet Mol Biol. 2005;4:Article32
pubmed: 16646851
J Magn Reson. 2003 Jan;160(1):65-73
pubmed: 12565051
J Biol Chem. 1998 Sep 11;273(37):23641-4
pubmed: 9726966
Ann Pediatr Cardiol. 2014 Sep;7(3):221-6
pubmed: 25298701
J Biomol NMR. 2001 May;20(1):71-5
pubmed: 11430757
Nat Genet. 2013 Jun;45(6):592-601
pubmed: 23644491
Nat Genet. 2017 Feb;49(2):289-295
pubmed: 27941797
Mol Cell Biol. 2008 Oct;28(19):6010-21
pubmed: 18644858
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1950-4
pubmed: 8127913

Auteurs

Alfredo M Valencia (AM)

Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Chemical Biology Program, Harvard University, Cambridge, MA 02138, USA.

Clayton K Collings (CK)

Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Hai T Dao (HT)

Department of Chemistry, Princeton University, Princeton, NJ 08544, USA.

Roodolph St Pierre (R)

Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Chemical Biology Program, Harvard University, Cambridge, MA 02138, USA.

Yung-Chih Cheng (YC)

F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.

Junwei Huang (J)

F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.

Zhen-Yu Sun (ZY)

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

Hyuk-Soo Seo (HS)

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

Nazar Mashtalir (N)

Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Dawn E Comstock (DE)

Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Program in Immunology, Harvard Medical School, Boston, MA 02115, USA.

Olubusayo Bolonduro (O)

Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Nicholas E Vangos (NE)

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

Zoe C Yeoh (ZC)

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

Mary Kate Dornon (MK)

F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.

Crystal Hermawan (C)

F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.

Lee Barrett (L)

F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.

Sirano Dhe-Paganon (S)

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Clifford J Woolf (CJ)

F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.

Tom W Muir (TW)

Department of Chemistry, Princeton University, Princeton, NJ 08544, USA.

Cigall Kadoch (C)

Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: cigall_kadoch@dfci.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH